Emma Lees, Senior Vice President of Oncology Discovery and Cambridge Site Head at Bristol Myers Squibb, shared on LinkedIn:
“After 8 fantastic years, I’m leaving Bristol Myers Squibb. It is bittersweet moment. BMS has been a place where I’ve grown, been challenged, and been part of something that truly matters.
I’ve had the privilege of working alongside brilliant minds on science that pushes the boundaries of medicine, always guided by the patients who are the reason behind every decision, milestone, and late night.
Helping advance important new drugs into the clinic I relish with pride, and establishing BMS’s research presence in Cambridge with our beautiful research facility at Cambridge Crossing (CX) has been a privilege.
To the team we built and to the many BMS colleagues and collaborators around the globe who have become trusted friends: thank you. You made the hard days easier and the good days even better.
On to the next chapter…
Thank you, BMS. Its been an honor.”
